Truist Securities Maintains Hold on Pediatrix Medical Group, Lowers Price Target to $15
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst David Macdonald maintains a 'Hold' rating on Pediatrix Medical Group (NYSE:MD) and lowers the price target from $16 to $15.
October 11, 2023 | 7:53 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Truist Securities has maintained a 'Hold' rating on Pediatrix Medical Group and lowered the price target from $16 to $15.
The news directly pertains to Pediatrix Medical Group (MD). The lowered price target could indicate a less optimistic outlook for the company, but the maintained 'Hold' rating suggests that the analyst does not recommend selling the stock at this time. This could have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100